Search Results - "Segurado, Óscar"

Treatment with sotrovimab for SARS-CoV-2 infection in a cohort of high-risk kidney transplant recipients by Villanego, Florentino, Mazuecos, Auxiliadora, Cubillo, Beatriz, Merino, M José, Poveda, Inmaculada, Saura, Isabel M, Segurado, Óscar, Cruzado, Leónidas, Eady, Myriam, Zárraga, Sofía, Aladrén, M José, Cabello, Sheila, López, Verónica, González, Esther, Lorenzo, Inmaculada, Espí-Reig, Jordi, Fernández, Constantino, Osma, July, Ruiz-Fuentes, M Carmen, Toapanta, Néstor, Franco, Antonio, Burballa, Carla C, Muñoz, Miguel A, Crespo, Marta, Pascual, Julio

“…Background Sotrovimab is a neutralizing monoclonal antibody (mAb) that seems to remain active against recent severe acute respiratory syndrome coronavirus 2…”
Get full text

IgA de novo en trasplante renal tras vacunación frente a SARS-CoV-2 by Alonso, Marta, Villanego, Florentino, Segurado, Óscar, Vigara, Luis Alberto, Orellana, Cristhian, Quiros, Pedro, García, Teresa, Mazuecos, Auxiliadora

Get full text

Experiencia en vida real con terapias frente a COVID-19 leve-moderada en trasplantados renales: ¿cómo tratar a partir de ahora a los pacientes con enfermedad renal crónica? by Alonso, Marta, Villanego, Florentino, Vigara, Luis Alberto, Rodríguez, María Eugenia, Eady, Myriam, García, Ana, Mínguez, María Carmen, Montero, María Elisa, Segurado, Óscar, García, Teresa, Mazuecos, Auxiliadora

Get full text

Discrepancy Between Multibiomarker Disease Activity and Clinical Disease Activity Scores in Patients With Persistently Active Rheumatoid Arthritis by Fleischmann, Roy, Liu, Jingyu, Zhu, Julie, Segurado, Oscar G., Furst, Daniel E.

“…Objective Responsive assessment of disease activity in patients who have rheumatoid arthritis (RA) is necessary to evaluate therapeutic efficacy and guide…”
Get full text

Novel therapies for graft versus host disease with a focus on cell therapies by Zeiser, Robert, Ringden, Olle, Sadeghi, Behnam, Gonen-Yaacovi, Gil, Segurado, Oscar G.

“…Graft versus host disease (GVHD) can occur at any period post allogeneic hematopoietic stem cell transplantation as a common clinical complication contributing…”
Get full text

Multibiomarker disease activity score and C-reactive protein in a cross-sectional observational study of patients with rheumatoid arthritis with and without concomitant fibromyalgia by Lee, Yvonne C, Hackett, James, Frits, Michelle, Iannaccone, Christine K, Shadick, Nancy A, Weinblatt, Michael E, Segurado, Oscar G, Sasso, Eric H

“…To examine the association between a multibiomarker disease activity (MBDA) score, CRP and clinical disease activity measures among RA patients with and…”
Get full text

Relative efficiencies of physician/assessor global estimates and patient questionnaire measures are similar to or greater than joint counts to distinguish adalimumab from control treatments in rheumatoid arthritis clinical trials by PINCUS, Theodore, AMARA, Ingrid, SEGURADO, Oscar G, BERGMAN, Martin, KOCH, Gary G

“…OBJECTIVE: To estimate relative efficiencies of the 7 rheumatoid arthritis (RA) Core Data Set measures to distinguish adalimumab from control treatments in 4…”
Get full text

Real-world experience with mild-moderate COVID-19 therapies in kidney transplant patients: How to treat patients with chronic kidney disease from now on? by Alonso, Marta, Villanego, Florentino, Vigara, Luis Alberto, Rodríguez, María Eugenia, Eady, Myriam, García, Ana, Mínguez, María Carmen, Montero, María Elisa, Segurado, Oscar, García, Teresa, Mazuecos, Auxiliadora

Get full text

An index of patient reported outcomes (PRO-Index) discriminates effectively between active and control treatment in 4 clinical trials of adalimumab in rheumatoid arthritis by PINCUS, Theodore, CHUNG, Cecilia, SEGURADO, Oscar G, AMARA, Ingrid, KOCH, Gary G

“…OBJECTIVE: To analyze 2 indices composed of the 3 patient reported outcomes (PRO) in the American College of Rheumatology (ACR) Core Data Set--physical…”
Get full text

Clinical Assessment of Pain, Tolerability, and Preference of an Autoinjection Pen Versus a Prefilled Syringe for Patient Self-Administration of the Fully Human, Monoclonal Antibody Adalimumab: The TOUCH Trial by Kivitz, Alan, Cohen, Steven, Dowd, James Edward, Edwards, William, Thakker, Suman, Wellborne, Frank R., Renz, Cheryl L., Segurado, Oscar G.

“…Adalimumab is a therapeutic monoclonal antibody for SC administration by 2 single-use injection devices providing bioequivalent amounts of adalimumab: a…”
Get full text

Cost-Effectiveness of Sequential Therapy with Tumor Necrosis Factor Antagonists in Early Rheumatoid Arthritis by DAVIES, Andrew, CIFALDI, Mary A, SEGURADO, Oscar G, WEISMAN, Michael H

“…Objective To estimate the comparative lifetime cost-effectiveness of sequenced therapy with tumor necrosis factor (TNF) antagonists as the initial therapeutic…”
Get full text

Brief Report: Enhancement of Patient Recruitment in Rheumatoid Arthritis Clinical Trials Using a Multi‐Biomarker Disease Activity Score as an Inclusion Criterion by van Vollenhoven, Ronald F., Bolce, Rebecca, Hambardzumyan, Karen, Saevarsdottir, Saedis, Forslind, Kristina, Petersson, Ingemar F., Sasso, Eric H., Hwang, C. C., Segurado, Oscar G., Geborek, Pierre

“…Objective Rheumatoid arthritis (RA) clinical trials often exclude patients who have low C‐reactive protein (CRP) levels, which slows enrollment into the trial…”
Get full text

HUMIRA pen: a novel autoinjection device for subcutaneous injection of the fully human monoclonal antibody adalimumab by Kivitz, Alan, Segurado, Oscar G

“…The HUMIRA (adalimumab) Pen is a novel, integrated, disposable autoinjection delivery system for the subcutaneous injection of adalimumab. Adalimumab is a…”
Get more information

5774 REAL-WORLD EXPERIENCE WITH COVID-19 THERAPY IN KIDNEY TRANSPLANT PATIENTS DURING THE OMICRON VARIANT PERIOD by Fernández, Florentino Villanego, Alonso, Marta, Sánchez, Luis Alberto Vigara, Mateos, Maria Eugenia Rodríguez, Alonso, Myriam Eady, García-Doncel, Ana García, Mañanes, María del Carmen Mínguez, Escobar, María Elisa Montero, Tostón, Óscar Segurado, Garcia, Teresa, Mazuecos, Auxiliadora

Get full text

IgA de novo en trasplante renal tras vacunación frente a SARS-CoV-2 by Alonso, Marta, Villanego, Florentino, Segurado, Óscar, Vigara, Luis Alberto, Orellana, Cristhian, Quiros, Pedro, García, Teresa, Mazuecos, Auxiliadora

Get full text

Hypocalcaemia, hyperphosphataemia and elevated parathyroid hormone, a difficult differential diagnosis? by Fraile-Gómez, Pilar, Blanc, Marc H, Segurado-Tostón, Óscar, García-Cosmes, Pedro, Tabernero-Romo, José M

Get more information

Abstract 2241: Comparison of rare pathogenic germline variants associated with cancer predisposition syndrome in Taiwan and USA populations by Gulzar, Zulfiqar, Lucas, Julian, Atkins, Alex, Su, stephen, Segurado, Oscar, Mei, Rui

“…Objective To evaluate the analytical performance of a 98-gene NGS panel designed to detect highly- penetrant, rare pathogenic germline variants, strongly…”
Get full text

Abstract 3652: Analytical validation of a novel circulating tumor DNA detection platform for targeted and immunotherapy selection by Gupta, Pratyush, Lucas, Julian, Atkins, Alex, Tsai, Wen-Sy, Marfatia, Twinkal, Chang, Shih-En, Segurado, Oscar, Mei, Rui

“…Introduction Comprehensive genomic profiling of solid tumors using circulating tumor DNA (ctDNA) has enabled the detection of all NCCN guideline-recommended…”
Get full text

Prospective clinical study of circulating tumor cells for colorectal cancer screening by Tsai, Wen-Sy, Nimgaonkar, Ashish, Segurado, Oscar, Chang, Ying, Hsieh, Ben, Shao, Hung-Jen, Wu, Jen-chia, Lai, Jr-Ming, Javey, Mana, Watson, Drew, Mei, Rui

“…Abstract only 556 Background: Colorectal cancer (CRC) is among the most preventable cancers when precancerous lesions are detected at an early stage. Current…”
Get full text

MP559EVALUATION OF CONCORDANCE BETWEEN DIALYSATE/PLASMA (D/P) PHOSPHORUS AND D/P CREATININE IN PERITONEAL DIALYSIS by Coloma, Ana, Sierra, Milagros, Balda, Sagrario, Gil, Antonio, Artamendi, Marta, Gil, Fernando, Dall'Anese, Cecilia, Segurado, Oscar, Huarte, Emma

Get full text